The Coronavirus Thread

[Scot Dutchy]

Do the 7 days not count from the day the minister made the decision? That's already two weeks ago.

Anyways, since the parliament approved the pandemic law recently, I am positive they will not turn into conspiracy nuts overnight.

As far as I understand it is when it comes into force. No exact laws have been passed. These are all Ministerial Regulations issued under the legal framework of health protection which can be used for emergencies ie. flooding, fires etc. so that is what being used just now. Going the whole path of bill to law takes weeks at the best and years at the worst.

[Scot Dutchy]

You cant trust any data:

Oxford/AstraZeneca Covid vaccine has 70% efficacy, full trial data shows

Newly published data shows 90% efficacy only in small group who got half-dose first

The Oxford/AstraZeneca Covid vaccine has efficacy of 90% in a small group who got a half-dose first, but only 62% in the majority, full trial data newly published in the Lancet has confirmed.

The results may create a quandary for regulatory bodies, which will have to decide on how the vaccine should be used if they approve it.

Oxford University and its partner, AstraZeneca, are seeking regulatory approval for their much-anticipated vaccine on the basis that it has 70% efficacy after pooling the results from trials in the UK and Brazil.

But it is the individual regulatory bodies in the UK, Europe and the US that will have to decide which dosing regimen is appropriate if they give it the go-ahead.

FFS they lie about everything. Keep drinking the kool-aid.

[NineBerry]

No one is lying. The numbers were reported like that from the beginning. There is even a very good scientific explanation why giving a smaller dose the first time and the full dose the second time works better with the platform used by the Oxford vaccine (using another virus hull as vector).

[pErvinalia]

You cant trust any data:

Oxford/AstraZeneca Covid vaccine has 70% efficacy, full trial data shows

Newly published data shows 90% efficacy only in small group who got half-dose first

The Oxford/AstraZeneca Covid vaccine has efficacy of 90% in a small group who got a half-dose first, but only 62% in the majority, full trial data newly published in the Lancet has confirmed.

The results may create a quandary for regulatory bodies, which will have to decide on how the vaccine should be used if they approve it.

Oxford University and its partner, AstraZeneca, are seeking regulatory approval for their much-anticipated vaccine on the basis that it has 70% efficacy after pooling the results from trials in the UK and Brazil.

But it is the individual regulatory bodies in the UK, Europe and the US that will have to decide which dosing regimen is appropriate if they give it the go-ahead.

FFS they lie about everything. Keep drinking the kool-aid.

Who's lying? This data has been reported from the start.

[Brian Peacock]

Plague ship! A Covid-safe “cruise to nowhere” that took Singaporean passengers on a no-stopovers jaunt has ended after one of the passengers tested positive for coronavirus.

[Brian Peacock]

You cant trust any data:

Oxford/AstraZeneca Covid vaccine has 70% efficacy, full trial data shows

Newly published data shows 90% efficacy only in small group who got half-dose first

The Oxford/AstraZeneca Covid vaccine has efficacy of 90% in a small group who got a half-dose first, but only 62% in the majority, full trial data newly published in the Lancet has confirmed.

The results may create a quandary for regulatory bodies, which will have to decide on how the vaccine should be used if they approve it.

Oxford University and its partner, AstraZeneca, are seeking regulatory approval for their much-anticipated vaccine on the basis that it has 70% efficacy after pooling the results from trials in the UK and Brazil.

But it is the individual regulatory bodies in the UK, Europe and the US that will have to decide which dosing regimen is appropriate if they give it the go-ahead.

FFS they lie about everything. Keep drinking the kool-aid.

You're probably in the high priority group for early vaccination. Are you going to accept the offer when it comes?

[rainbow]

Do the 7 days not count from the day the minister made the decision? That's already two weeks ago.

Anyways, since the parliament approved the pandemic law recently, I am positive they will not turn into conspiracy nuts overnight.

Dutch conspiracy nuts are the best.

[rainbow]

[Scot Dutchy]

You cant trust any data:

Oxford/AstraZeneca Covid vaccine has 70% efficacy, full trial data shows

Newly published data shows 90% efficacy only in small group who got half-dose first

The Oxford/AstraZeneca Covid vaccine has efficacy of 90% in a small group who got a half-dose first, but only 62% in the majority, full trial data newly published in the Lancet has confirmed.

The results may create a quandary for regulatory bodies, which will have to decide on how the vaccine should be used if they approve it.

Oxford University and its partner, AstraZeneca, are seeking regulatory approval for their much-anticipated vaccine on the basis that it has 70% efficacy after pooling the results from trials in the UK and Brazil.

But it is the individual regulatory bodies in the UK, Europe and the US that will have to decide which dosing regimen is appropriate if they give it the go-ahead.

FFS they lie about everything. Keep drinking the kool-aid.

You're probably in the high priority group for early vaccination. Are you going to accept the offer when it comes?

Well I actually wont be. Care helpers and care homes are first here. I will probably take it for the sake of the herd.

[NineBerry]

[Scot Dutchy]

If you have an allergy watch out with the vaccine.

Here is the new MHRA advice relating to the Pfizer vaccine and people with a significant history of allergic reactions. It says:

Any person with a history of a significant allergic reaction to a vaccine, medicine or food (such as previous history of anaphylactoid reaction or those who have been advised to carry an adrenaline autoinjector) should not receive the Pfizer/BioNtech vaccine.

Resuscitation facilities should be available at all times for all vaccinations. Vaccination should only be carried out in facilities where resuscitation measures are available.

Pfizer has said that its coronavirus vaccine was “well tolerated” during trials. Commenting on the news that people with a significant history of allergic reactions have been told not to get the vaccine for now because two people suffered adverse reactions yesterday (see 9.50am and 10.02am), a Pfizer spokewoman said:

We have been advised by MHRA of two yellow card reports that may be associated with allergic reaction due to administration of the Covid-19 BNT162b2 vaccine.

As a precautionary measure, the MHRA has issued temporary guidance to the NHS while it conducts an investigation in order to fully understand each case and its causes. Pfizer and BioNTech are supporting the MHRA in the investigation.

In the pivotal phase three clinical trial, this vaccine was generally well tolerated with no serious safety concerns reported by the independent data monitoring committee. The trial has enrolled over 44,000 participants to date, over 42,000 of whom have received a second vaccination.

https://www.theguardian.com/politics/li ... st-updates

[Brian Peacock]

I thought Merkel spoke very passionately today - basically saying that the efforts and gains made so far shouldn't be wiped away by people acting as if Covid has gone away for 3 days over Christmas. If only politicians in the UK could be so straightforward...

[Scot Dutchy]

American big pharma playing politics?

Covid vaccines: US regulator sceptical over AstraZeneca model

Vaccine developed in Oxford criticised by FDA with efficacy rates and trials delaying official take-up

For a man presenting landmark results from trials of a vaccine that it is hoped will save the world from a devastating pandemic, Sir Menelas Pangalos did not look cheerful on Wednesday.

Pangalos, executive vice-president of biopharmaceuticals R&D at AstraZeneca, and his colleagues are undoubtedly exhausted, having been working round the clock on the coronavirus vaccine with Oxford University since April. But they are now dealing with a sizeable new headache – the doubts of the US regulator.

It is clear that in spite of the critical need for coronavirus vaccines, the Food and Drug Administration is not going to rush to approve the vaccine developed by Oxford University and AstraZeneca, even though the US, through its “Operation Warp Speed”, has put in substantial funding and ordered 300m doses.

Unlike Pfizer/BioNTech and Moderna’s mRNA products, the AstraZeneca vaccine is cheap, can be stored at ordinary fridge temperatures, is easy to manufacture and presents the best hope at the moment for a vaccine for the billions rather than the few.

But while the UK, the rest of Europe, and Canada and India could approve it in the coming weeks, the US, which currently has the world’s biggest epidemic, will have to wait.

So when Pfizer/BioNTech vaccine was proven to be only 70% efficient a halt was called on approval of the Oxford vaccine. Playing silly buggers?

[Brian Peacock]

Playing silly buggers, or just each regulatory authority adhering to its own rules and following its own processes.

[Scot Dutchy]

Playing silly buggers, or just each regulatory authority adhering to its own rules and following its own processes.

Being dictated to by Big Pharma.